Concepedia
Statistics
Publications
5
Citations
202
H-Index
Active since
2003
Affiliations
Oncology Hematology Care(Current)
Tennessee Oncology
Sarah Cannon
Mercy Medical Center
Florida Cancer Specialists & Research Institute
David R. Drosick is an author at Oncology Hematology Care specializing in oncology, medicine, and metastatic disease treatment.
Publications per year
2003–2017
Increased Rate of Brain Metastasis with Trastuzumab Therapy Not Associated with Impaired Survival
Elyse E. Lower, David R. Drosick, Robbin Blau et al. · Clinical Breast Cancer · 2003 · 105 citations
Medicine, Neurology, Oncology +15
A Phase II Trial of Gemcitabine/Carboplatin with or Without Trastuzumab in the First-Line Treatment of Patients with Metastatic Breast Cancer
Denise A. Yardley, Howard A. Burris, Lisa Simons et al. · Clinical Breast Cancer · 2008 · 43 citations
Medicine, Oncology, Pharmacology +15
TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer
Denise A. Yardley, Edward Arrowsmith, Brooke Daniel et al. · Breast Cancer Research and Treatment · 2017 · 27 citations
Medicine, Oncology, Pharmacology +14
Sorafenib Plus Ixabepilone as First-Line Treatment of Metastatic HER2-Negative Breast Cancer: A Sarah Cannon Research Institute Phase I/II Trial
Denise A. Yardley, Natalie R. Dickson, David R. Drosick et al. · Clinical Breast Cancer · 2016 · 17 citations
Addition of bevacizumab to three docetaxel regimens as adjuvant therapy for early stage breast cancer
Denise A. Yardley, Lowell L. Hart, David Waterhouse et al. · Breast Cancer Research and Treatment · 2013 · 10 citations
Medicine, Oncology, Pharmacology +11
1–5 of 5